Highlights NanoRepro AG

Equities

NN6

DE0006577109

Real-time Estimate Tradegate Other stock markets 15:40:13 10/05/2024 BST			5-day change	1st Jan Change
1.75 ^EUR	-3.58%		-7.34%	-14.54%

2023	NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	NanoRepro AG commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on April 29, 2022.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023	31/10/23	CI
NanoRepro AG commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on April 29, 2022.	21/05/23	CI
NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2022	04/05/23	CI
NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2022	27/09/22	CI
NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2021	13/06/22	CI
NanoRepro to Supply 41 Million Rapid COVID-19 Antigen Tests to Viromed	24/11/21	MT
NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2021	23/09/21	CI
NanoRepro : Secures CE Mark on Two SARS-CoV-2 Tests	14/06/21	MT
Nanorepro Ag Reports Earnings Results for the Full Year Ended December 31, 2020	20/05/21	CI
NanoRepro AG Signs Distribution Agreement for Romania, Moldova	18/06/15	CI
NanoRepro AG (DB:NN6) acquired brand alphabiol from Alphablom AG.	04/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer